Bayer Market Cap 2006-2019 | BAYRY

Bayer market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Bayer market cap as of July 31, 2020 is $61.46B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $61.459B $48.230B
Bayer AG, best known for its flagship product, Bayer Aspirin, produces a broad range of health care, crop protection, polymer, and chemical products that help diagnose and treat diseases, purify water, preserve local landmarks, protect crops, advance automobile safety and durability, and improve people's lives.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $383.760B 18.29
Roche Holding AG (RHHBY) Switzerland $295.170B 0.00
Pfizer (PFE) United States $213.750B 13.36
Merck (MRK) United States $202.534B 14.48
Novartis AG (NVS) Switzerland $187.994B 14.62
Novo Nordisk (NVO) Denmark $153.839B 25.62
AstraZeneca (AZN) United Kingdom $146.388B 28.46
Eli Lilly (LLY) United States $143.745B 21.94
AbbVie (ABBV) United States $140.158B 10.20
Sanofi (SNY) $131.342B 15.61
GlaxoSmithKline (GSK) United Kingdom $101.144B 13.26
H Lundbeck (HLUYY) Denmark $7.199B 0.00
Innoviva (INVA) United States $1.372B 6.58